Iron Dosing Pilot Study Using Model Predictive Control

Completed · Phase 4

Conditions studied: Renal Insufficiency, Chronic, Anemia, Iron Deficiency, Anemia of Chronic Kidney Disease

In brief

This is a pilot study to test the utility of an integrated approach in the management of the anemia of chronic kidney disease through the administration of both an erythropoietic stimulating agent and iron. Subjects will be studied for 6 months during which all iron dosing will be recommended using a computer based tool using model predictive control. Comparisons will be made to the 6 months prior to enrollment in to the study.

Key facts

Study ID

NCT03633656

Run by

University of Louisville

People needed

10

Starts

2019-02-01

Expected to finish

2019-08-30

Last updated by the study team

2021-04-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• chronic kidney disease
• anemia
• receiving intravenous iron

You may not qualify if…

• none

Where it is running

• University of Louisville — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.